A Nusinersen Sodium, SPINRAZA Intrathecal injection 12mg (5ml1) 11 cases, Lenalidomide... Tender

Procurement Summary

Country : Japan

Summary : A Nusinersen Sodium, SPINRAZA Intrathecal injection 12mg (5ml1) 11 cases, Lenalidomide hydrate capsules, Revlimid 5mg (10capsules4) 246 cases, Canakinumab (Genetical Recombination), ILARIS solution for...

Deadline : 01 Apr 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 29991805

Document Ref. No. :

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : NATIONAL UNIVERSITY CORPORATION
Yuji Arikawa, Procurement Section, Accounting Division, Finance Department, National University Corporation Kagoshima University, 1-21-24 Korimoto Kagoshima-shi 890-8580 Japan, TEL 099-285-7153
Japan

Tender Details

A Nusinersen Sodium, SPINRAZA Intrathecal injection 12mg (5ml×1) 11 cases, ??Lenalidomide hydrate capsules, Revlimid 5mg (10capsules×4) 246 cases, ??Canakinumab (Genetical Recombination), ILARIS solution for s.c injection 150mg (1ml×1) 20 vials, ...

Classification :
0004 Medical & Pharmaceutical Products

Summay of Notice :
? Official in charge of disbursement of the procuring entity : Hiroshi Miyata, Executive Vice President Financial Affairs, National University Corporation Kagoshima University

? Classification of the products to be procured : 4

? Nature and quantity of the products to be purchased :

A Nusinersen Sodium, SPINRAZA Intrathecal injection 12mg (5ml×1) 11 cases

B Lenalidomide hydrate capsules, Revlimid 5mg (10capsules×4) 246 cases

C Canakinumab (Genetical Recombination), ILARIS solution for s.c injection 150mg (1ml×1) 20 vials

D Eculizumab (Genetical Recombination), Soliris 300mg (30mg×1) 52 vials

E Infliximab (Genetical Recombination), REMICADE for I.V infusion100 (20ml×1) 1, 218 vials

F Pembrolizumab (Genetical Recombination), KEYTRUDA injection 100mg (4ml×1) 204 cases

? Delivery period : From 1 April, 2019 through 31 March, 2020

? Delivery place : Kagoshima University Hospital

? Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :

A not come under Article 2 and 3 of the Regulation concerning the Contract for Kagoshima University,

B have the Grade A, Grade B, Grade C or Grade D qualification during fiscal 2019 in the Kyushu?Okinawa area in sales of product for participating in tenders by Single qualification for every ministry and agency, or have the Grade A, Grade B, Grade C or Grade D qualification during fiscal 2019 in sales of product for participating in tenders by National University Corporation Kagoshima University,

C prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices,

D meet the qualification requirements which Executive Vice President Financial Affairs, National University Corporation Kagoshima University may specify in accordance with Article 4, section 6 of the Regulation concerning the Goods supply contract for Kagoshima University,

E not be currently under a suspension of business order as instructed by Executive Vice President Financial Affairs, National University Corporation Kagoshima University.

? Time limit of tender : 17 : 00 15 March, 2019

? Contact point for the notice : Yuji Arikawa, Procurement Section, Accounting Division, Finance Department, National University Corporation Kagoshima University, 1-21-24 Korimoto Kagoshima-shi 890-8580 Japan, TEL 099-285-7153

Documents

 Tender Notice